Abstract:OBJECTIVE:To investigate the effects of long-term hormone replacement therapy (HRT) on the breasts of postmenopausal women using mammary ultrasonography.METHODS:An open randomized clinical study was designed. The percutaneous estradiol gel was used in a cyclic regimen combined with micronized progesterone (MP) or medroxyprogesterone acetate (MPA). Sixty healthy women (natural menopause for 1 to 5 years) were recruited and divided into four groups according to the dosage of estrogen and two kinds of progestin. All were given for 25 days per month. Mammary ultrasonography was used to observe breast glandular section thickness, breast duct width, the morphology of lobular unit and the blood flow of color Doppler imaging at baseline and every year from the second to seventh year of HRT. The serum estradiol was also measured from the 15th to 25th day of the cycle. Breast pain was recorded by the subjects.RESULTS:(1) The breast glandular section thickness after HRT was larger than that of before HRT. The breast glandular section thickness became larger gradually over time while the breast duct width became smaller over time. The breast duct width of the fifth year of HRT was significantly different from that of the sixth year (P < 0.05). (2) Twenty-two persons had new breast structure changes after HRT, and the accumulated incidence was 41.5%. New solid lesions formation occurred in five subjects (8.3%) and new cyst formation occurred in one subject (1.7%). After the second year of HRT, the serum estradiol level of the subjects with breast structure changes was higher than that of without breast structure changes and in the sixth year of HRT, and the difference was significant (P < 0.05). After the second year of HRT, the breast glandular section thickness of the subjects with breast structure changes was larger than that of without breast structure changes and in the fifth and sixth year of HRT, the difference was significant (P < 0.05). (3) After HRT, the serum estradiol level of subjects with mastalgia was higher than that of without mastalgia and in the second and sixth follow-up year, the difference was significant (P < 0.05).CONCLUSIONS:There is an increasing trend of the percentage of glandular tissues of the breast after HRT. There is an increasing trend of the serum estradiol level and the breast glandular section thickness among the subjects with the breast structure changes; there is an increasing trend of the serum estradiol level among the subjects with mastalgia. Mammary ultrasonography can be used to monitor breast structure changes and breast lesions during HRT.

[Changes in pituitary gonadotropins according to body mass index and adipose tissue distribution, in postmenopausal women receiving different types of hormone replacement therapy]

[Application of Femoston in hormone replacement treatment-frozen embryo transfer and its clinical outcomes].

Effects on the Male Endocrine System of Long-term Treatment with Gonadotropin-releasing Hormone Agonists and Estrogens in Male-to-Female Transsexuals

[Monitoring the Breast Changes of Chinese Postmenopausal Women under Long-Term Hormone Replacement Therapy by Mammary Ultrasonography].

EFFECT OF HORMONE REPLACEMENT THERAPY ON SERUM LIPOPROTEIN AND APOLIPOPROTEIN

Effect of low- and high-fat intakes on the hormonal milieu of premenopausal women

Effect of hormone replacement therapy on growth hormone stimulation in women with premature ovarian failure

Insulin resistance and body composition in Turner syndrome: Effect of sequential change in the route of estrogen administration

Follicle-stimulating hormone receptor gene polymorphisms influence Body Mass Index, metabolism, and bone mineral density in postmenopausal women

Adipose Tissue Sex Steroids in Postmenopausal Women With and Without Menopausal Hormone Therapy

Effects of hormone replacement therapy on glucose and lipid metabolism in peri- and postmenopausal women with a history of menstrual disorders

Change in Metabolic Parameters and Reproductive Hormones from Baseline to 6-Month Hormone Therapy

Long-term post-menopausal hormone therapy and serum HDL-C, total cholesterol and triglycerides

Relation of BMI and physical activity to sex hormones in postmenopausal women

The pattern of lipids and lipoproteins during the menopausal transition in Chinese women.

Effect of body mass index on progesterone level on trigger day in gonadotropin-releasing hormone antagonist cycles

Effects Of Menopause On Hepatic 11 Beta-Hydroxysteroid Dehydrogenase Type 1 Activity And Adrenal Sensitivity To Adrenocorticotropin In Healthy Non-Obese Women

Cardiometabolic Risk Factors and Endogenous Sex Hormones in Postmenopausal Women: A Cross-Sectional Study

Effects of visceral obesity and diabetes on secretion function of pituitary gonadotroph cells in postmenopausal women

The Effects of Hormone Replacement Therapy on Ocular Surface and Tear Function Tests in Postmenopausal Women

Effects of gender-affirming hormone therapy on body fat: a retrospective case‒control study in Chinese transwomen